Compare Danaos Corporation (DAC) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaos Corporation vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Danaos Corporation trades at $169.09 (market cap $3.10B), while Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 4.1× Danaos Corporation's market cap, and Danaos Corporation pays a 2.35% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Danaos Corporation for 25 Days and Halozyme Therapeutics Inc. Common Stock for 1 Days on average.
| DAC | HALO | |
|---|---|---|
Market Cap | $3.10B | $12.58B |
Volume | 286,008 | 2,179,278 |
Sector | Industrials | Health |
52-Week High | $170.22 | $115.22 |
52-Week Low | $84.05 | $61.63 |
Typical Hold Time | 25 Days | 1 Days |
Enterprise Value | $3.08B | $14.49B |
Dividend Yield | 2.35% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DAC trades at $169.09, up 2.8% today, with a bullish technical signal and strong fundamental metrics. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $7.29 exceeding the $6.80 estimate. Valuation ratios are attractive, including a P/E of 5.76 and P/B of 0.76, while profitability remains high with a net income margin of 51.26%. Recent news highlights dividend declarations and institutional investment interest.
The outlook is positive given earnings momentum and shareholder returns via dividends, but risks include shipping market volatility and reliance on global trade flows. Analyst consensus is evenly split between Buy and Hold ratings, suggesting cautious optimism amid strong operational performance.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Danaos Corporation
Danaos is a leading international owner of containerships, providing seaborne transportation services globally. It charters its fleet of vessels to major shipping lines across Asia, Europe, and the Americas.
Read more on DAC →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
